Massive teen eczema registry launches to uncover disease patterns
NCT ID NCT06238765
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This observational registry will follow 1,500 adolescents aged 12–15 with moderate-to-severe atopic dermatitis (eczema) across North America and Europe. Researchers aim to document the disease's natural history, how it's managed, and long-term outcomes. Participants will be under the care of a dermatologist and may be on various medications. The study does not test any new drug but hopes to improve understanding of this chronic skin condition in teens.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could provide a clearer picture of how atopic dermatitis progresses and is managed in adolescents, potentially guiding better treatment approaches.
What could go wrong
As an observational study, it does not test a new treatment, so it won't directly improve outcomes. Results may take years and could be limited by the diversity of the participant group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CorEvitas, LLC
RECRUITINGWaltham, Massachusetts, 02451, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••